Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers

Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01845324

Enrollment

300

Registered

2013-05-03

Start date

2013-05-31

Completion date

2014-06-30

Last updated

2013-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Pregnancy

Keywords

Pregnancy, Diabetes Mellitus

Brief summary

The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.

Detailed description

In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventional measures of blood glucose measurements in this population. The investigators will try to assess whether measurement of the septum can be an earlier and better predictor of glucose control in this population.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* All consequtive pregnant women * with Diabetes Mellitus - Gestational and non Gestational

Exclusion criteria

.No willing to participate. * Suspected Heart anomaly

Design outcomes

Primary

Measure	Time frame	Description
width of fetal interventricula heart septum	2 years	The investigator will assess the width of the fetal interventricular septum in patients with diabetes.

Secondary

Measure	Time frame	Description
glucose control in patients with normal and abnormal interventricular septal width	2 years	The investigators will try to show that small interventricular septal width glucose correlates with good glucose control

Countries

Israel

Contacts

Primary ContactAlon Shrim, MD

alon.shrim@gmail.com+972-4-6188224

Outcome results